Forte Asset Management’s iShares Core 80/20 Aggressive Allocation ETF AOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Buy
3,033
+112
+4% +$10.2K 0.12% 69
2025
Q4
$262K Buy
2,921
+522
+22% +$46.5K 0.12% 67
2025
Q3
$211K Buy
+2,399
New +$204K 0.1% 71
2024
Q1
Sell
-8,233
Closed -$568K 59
2023
Q4
$568K Hold
8,233
0.39% 39
2023
Q3
$523K Buy
8,233
+760
+10% +$49.9K 0.35% 38
2023
Q2
$496K Buy
7,473
+50
+0.7% +$3.22K 0.32% 42
2023
Q1
$472K Buy
7,423
+50
+0.7% +$3.12K 0.31% 43
2022
Q4
$441K Buy
7,373
+75
+1% +$4.44K 0.29% 50
2022
Q3
$405K Buy
7,298
+66
+0.9% +$4.01K 0.27% 52
2022
Q2
$433K Buy
+7,232
New +$460K 0.3% 52

Other funds holding AOA

Forte Asset Management's AOA Position: Q1 2026 in Review

Forte Asset Management increased its iShares Core 80/20 Aggressive Allocation ETF (AOA) stake by 3.8% in Q1 2026, buying an estimated $10.2K and bringing the position to 3,033 shares worth $268K. The position accounts for 0.12% of the portfolio, ranked #69.

Forte Asset Management first reported a position in AOA in Q2 2022 and has held it in 10 quarters since. The position peaked at $568K in Q4 2023. 403 funds tracked by Wall St. Rank hold AOA as of Q1 2026.

  • Forte Asset Management held 3,033 shares of iShares Core 80/20 Aggressive Allocation ETF worth $268K as of Q1 2026.
  • Forte Asset Management bought 112 iShares Core 80/20 Aggressive Allocation ETF shares in Q1 2026, an estimated $10.2K.
  • iShares Core 80/20 Aggressive Allocation ETF made up 0.12% of Forte Asset Management's portfolio in Q1 2026, its #69 holding.
  • Forte Asset Management first reported a position in iShares Core 80/20 Aggressive Allocation ETF in Q2 2022 and has held it in 10 quarters since.
  • Forte Asset Management's iShares Core 80/20 Aggressive Allocation ETF position peaked at $568K in Q4 2023.
  • 403 funds tracked by Wall St. Rank held iShares Core 80/20 Aggressive Allocation ETF as of Q1 2026.

Based on Forte Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.